Acute Budd-Chiari syndrome associated with activated protein C resistance during intravenous anticoagulant treatment

Bülent O. Yildiz, Betül Oran, Yahya Büyükaşik, Ibrahim C. Haznedaroǧlu, Saruhan Çekirge, Şerafettin Kirazli

Research output: Contribution to journalArticlepeer-review

Abstract

The Budd-Chiari syndrome is a rare but serious condition defined as hepatic venous outflow obstruction. This article presents a case of acute Budd-Chiari syndrome in a 43-year-old woman with activated protein C resistance while she was being treated with intravenous heparin infusion for previously documented deep venous thrombosis. Activated protein C resistance caused by factor V Leiden mutation has emerged as the most prevalent hereditary cause of venous thromboembolism and should be considered as an etiologic factor in patients with Budd-Chiari syndrome.

Original languageEnglish (US)
Pages (from-to)220-223
Number of pages4
JournalClinical and Applied Thrombosis/Hemostasis
Volume4
Issue number3
DOIs
StatePublished - Jul 1998
Externally publishedYes

Keywords

  • Activated protein C resistance
  • Budd-Chiari syndrome

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Acute Budd-Chiari syndrome associated with activated protein C resistance during intravenous anticoagulant treatment'. Together they form a unique fingerprint.

Cite this